Yeast species-specific, differential inhibition of β-1,3-glucan synthesis by poacic acid and caspofungin
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The rise of widespread antifungal resistance fuels the need to explore new classes of inhibitory molecules as potential novel inhibitors. Recently a plant natural product poacic acid (PA) was shown to inhibit β-1,3-glucan synthesis, and to have antifungal activity against a range of plant pathogens and against Saccharomyces cerevisiae. As with the echinocandins, such as caspofungin, PA targets the synthesis of cell wall β-1,3-glucan and has potential utility in the treatment of medically important fungi. However, the antifungal activity of PA against human pathogenic Candida species has not been explored and the precise mode of action of this compound is not understood. Here, we show that PA sensitivity is regulated by the calcineurin pathway and that susceptibility to PA varied significantly between Candida species, but did not correlate with in vitro β-glucan synthase activity, cell wall β-glucan content or the sensitivity of the species to caspofungin. Strains with point mutations (S645Y or S645P) in the hotspot1 region of the β-1,3-glucan synthase subunit Fks1, had decreased sensitivity to caspofungin but increased sensitivity to PA. C. guilliermondii, C. orthopsilosis, and C. parapsilosis were more sensitive to PA than C. albicans, C. dubliniensis, C. tropicalis, and C. glabrata. These observations suggest that there are significant differences in the mode of action of PA and caspofungin and that PA or PA analogues are not likely to have broad spectrum activity in the treatment of Candida infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 1×
“T The three echinocandins caspofungin (CSF), micafungin, and anidulafungin, are the newest class of antifungal agents on the market and have been clinically approved by the US Food and Drug Administration since 2001 (Pappas et al., 2009; Pound et al., 2010; Pfaller, 2012; Perlin, 2015b).”
BackgroundLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
The Fungal Cell Wall: Structure, Biosynthesis, and Function
Gow, N. A. R., Latge, J.-P., & Munro, C. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0035-2016 · Cited by 1,423 · cited 3×
“Depending on the fungus and growth conditions, the proportion and structural composition of cell wall components varies considerably (Free, 2013; Erwig et al., 2016; Gow et al., 2016; Gow et al., 2017).”
BackgroundSelf-citationAntifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Noble, S. M., French, S., Kohn, L. A., Chen, V., & Johnson, A. D. (2010) · Nature Genetics · doi:10.1038/ng.605 · Cited by 678 · cited 2×
“, 2013), and 4) mutants in genes encoding glucan synthase, glucosidase, or glucosyltransferase (PHR1, PHR2, CWH41, SMI1, KRE62, C1_14060W, XOG1, PGA4 and PGA5) (Fonzi, 1999; Noble et al., 2010).”
Interactions of fungal pathogens with phagocytes
Erwig, L. P., & Gow, N. A. R. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.21 · Cited by 626
Self-citationFungal Cell Wall Organization and Biosynthesis
Free, S. J. (2013) · Advances in Genetics · doi:10.1016/b978-0-12-407677-8.00002-6 · Cited by 576 · cited 1×
“Depending on the fungus and growth conditions, the proportion and structural composition of cell wall components varies considerably (Free, 2013; Erwig et al., 2016; Gow et al., 2016; Gow et al., 2017).”
BackgroundStimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
Walker, L. A., Munro, C. A., de Bruijn, I., Lenardon, M. D., McKinnon, A., & Gow, N. A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000040 · Cited by 445
Self-citationPark, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434 · cited 1×
“…in Fks1, one of three major “hotspots” regions in the predicted external face of the β-1,3-glucan synthase transmembrane protein (Kurtz et al., 1996; Park et al., 2005; Garcia-Effron et al., 2008; Garcia-Effron et al., 2009a; Johnson et al., 2011; Johnson and Edlind, 2012; Perlin, 2015b;…”
Echinocandin resistance in Candida.
Perlin, D. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ791 · Cited by 374 · cited 7×
“T The three echinocandins caspofungin (CSF), micafungin, and anidulafungin, are the newest class of antifungal agents on the market and have been clinically approved by the US Food and Drug Administration since 2001 (Pappas et al., 2009; Pound et al., 2010; Pfaller, 2012; Perlin, 2015b).”
BackgroundInfluentialHsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000532 · Cited by 362
Nett, J. E., & Andes, D. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.012 · Cited by 351
Sanglard, D., Ischer, F., Marchetti, O., Entenza, J., & Bille, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03495.x · Cited by 350
Importance of the Candida albicans cell wall during commensalism and infection
Gow, N. A., & Hube, B. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.04.005 · Cited by 347
Self-citationCalcineurin is essential for survival during membrane stress in Candida albicans
Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J. R., McCusker, J. H., & Heitman, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.546 · Cited by 342 · cited 3×
“We showed here that deletion of CNA1 or CNB1 increased the CSF sensitivity in C. albicans.”
MethodLaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329 · cited 1×
“The Ca2+/calcineurin pathway is also important for cell wall remodelling and stress responses to caspofungin (Bader et al., 2006; Munro et al., 2007; Walker et al., 2008; Singh et al., 2009; Kaneko et al., 2010; Lafayette et al., 2010).”
BackgroundGarcia-Effron, G., Katiyar, S. K., Park, S., Edlind, T. D., & Perlin, D. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-08 · Cited by 323 · cited 1×
“…major “hotspots” regions in the predicted external face of the β-1,3-glucan synthase transmembrane protein (Kurtz et al., 1996; Park et al., 2005; Garcia-Effron et al., 2008; Garcia-Effron et al., 2009a; Johnson et al., 2011; Johnson and Edlind, 2012; Perlin, 2015b; Kolaczkowska et al., 2016;…”
BackgroundGarcia-Effron, G., Lee, S., Park, S., Cleary, J. D., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00443-09 · Cited by 323
Mechanisms of echinocandin antifungal drug resistance
Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313
Fungal ß(1,3)-D-glucan synthesis
Douglas, C. M. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.55.66 · Cited by 312
Munro, C. A., Selvaggini, S., De Bruijn, I., Walker, L., Lenardon, M. D., Gerssen, B., Milne, S., Brown, A. J. P., & Gow, N. A. R. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05588.x · Cited by 309
Self-citationEchinocandin resistance: an emerging clinical problem?
Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299
Garcia-Effron, G., Park, S., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01162-08 · Cited by 256 · cited 1×
“…potential synergies between PA and chitin synthesis inhibitors nikkomycin Z (NKZ) (a competitive inhibitor of chitin synthase) and CFW (which can have a cidal effect against fungi by binding to nascent chitin and disrupting chitin chain maturation) (Roncero et al., 1985; Gaughran et al., 1994).”
Plaine, A., Walker, L., Da Costa, G., Mora-Montes, H. M., McKinnon, A., Gow, N. A. R., Gaillardin, C., Munro, C. A., & Richard, M. L. (2008) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2008.08.003 · Cited by 238
Self-citationElevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin
Walker, L. A., Gow, N. A. R., & Munro, C. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01486-12 · Cited by 214
Self-citationElevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo
Lee, K. K., MacCallum, D. M., Jacobsen, M. D., Walker, L. A., Odds, F. C., Gow, N. A. R., & Munro, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00683-11 · Cited by 209 · cited 4×
“All positive transformations were confirmed by the DNA sequencing analysis as previously described (Lee et al., 2012).”
BackgroundMethodInfluentialSelf-citationMunro, C. A., Bates, S., Buurman, E. T., Hughes, H. B., MacCallum, D. M., Bertram, G., Atrih, A., Ferguson, M. A. J., Bain, J. M., Brand, A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411413200 · Cited by 200 · cited 1×
“…1996; Munro et al., 2003), 3) mannosylation mutants (OCH1, PMR1, MNN2 family, MNN4, MNT1, MNT2, and MNS1) (Hobson et al., 2004; Bates et al., 2005; Munro et al., 2005; Bates et al., 2006; Mora-Montes et al., 2007; Hall et al., 2013), and 4) mutants in genes encoding glucan synthase, glucosidase,…”
Self-citationFonzi, W. A. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.22.7070-7079.1999 · Cited by 193 · cited 2×
“…2004; Bates et al., 2005; Munro et al., 2005; Bates et al., 2006; Mora-Montes et al., 2007; Hall et al., 2013), and 4) mutants in genes encoding glucan synthase, glucosidase, or glucosyltransferase (PHR1, PHR2, CWH41, SMI1, KRE62, C1_14060W, XOG1, PGA4 and PGA5) (Fonzi, 1999; Noble et al., 2010).”
BackgroundStevens, D. A., Ichinomiya, M., Koshi, Y., & Horiuchi, H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00563-06 · Cited by 193
Ben-Ami, R., Garcia-Effron, G., Lewis, R. E., Gamarra, S., Leventakos, K., Perlin, D. S., & Kontoyiannis, D. P. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir351 · Cited by 162
Attenuated virulence of chitin-deficient mutants of Candida albicans.
Bulawa, C. E., Miller, D. W., Henry, L. K., & Becker, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10570 · Cited by 146
Hall, R. A., Bates, S., Lenardon, M. D., MacCallum, D. M., Wagener, J., Lowman, D. W., Kruppa, M. D., Williams, D. L., Odds, F. C., Brown, A. J. P., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003276 · Cited by 128 · cited 4×
“and MNS1) (Hobson et al., 2004; Bates et al., 2005; Munro et al., 2005; Bates et al., 2006; Mora-Montes et al., 2007; Hall et al., 2013), and 4) mutants in genes encoding glucan synthase, glucosidase, or glucosyltransferase (PHR1, PHR2, CWH41, SMI1, KRE62, C1_14060W, XOG1, PGA4 and PGA5) (Fonzi, 1999; Noble et al.”
BackgroundMethodInfluentialSelf-citationMunro, C. A., Whitton, R. K., Bleddyn Hughes, H., Rella, M., Selvaggini, S., & Gow, N. A. R. (2003) · Fungal Genetics and Biology · doi:10.1016/s1087-1845(03)00083-5 · Cited by 91
Self-citationBader, T., Schröppel, K., Bentink, S., Agabian, N., Köhler, G., & Morschhäuser, J. (2006) · Infection and Immunity · doi:10.1128/iai.00142-06 · Cited by 81 · cited 1×
“The Ca2+/calcineurin pathway is also important for cell wall remodelling and stress responses to caspofungin (Bader et al., 2006; Munro et al., 2007; Walker et al., 2008; Singh et al., 2009; Kaneko et al., 2010; Lafayette et al., 2010).”
BackgroundTranscriptional Analysis of the Candida albicans Cell Cycle
Côte, P., Hogues, H., & Whiteway, M. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-03-0210 · Cited by 72 · cited 1×
“, 2013a,b), therefore, cell wall integrity is constantly monitored via sensors located in the cell wall and membrane and at critical cell cycle check points (Roberts et al., 1983; Suzuki et al., 2004; Côte et al., 2009; Negishi et al., 2010; Gow et al., 2012; Negishi et al., 2016).”
BackgroundPhenotypic characterization of a Candida albicans strain deficient in its major exoglucanase
del Mar González, M., Díez-Orejas, R., Molero, G., álvarez, A. M., Pla, J., Pla, J., Nombela, C., & Sánchez-PéArez, M. (1997) · Microbiology · doi:10.1099/00221287-143-9-3023 · Cited by 47 · cited 2×
“The nascent polysaccharide matures into a β-glucan triple helix matures and subsequently undergoes structural modifications and crosslinking via a number of transglycosidase and glucan modifying enzymes such as Phr1, Phr2, the Chr family, Pga4, Pga5, Xog1, Eng1, Bgl2, and Kre62 (González et al., 1997; Plaine et al., 2…”
BackgroundCell wall stress induces alternative fungal cytokinesis and septation strategies
Walker, L. A., Lenardon, M. D., Preechasuth, K., Munro, C. A., & Gow, N. A. R. (2013) · Journal of Cell Science · doi:10.1242/jcs.118885 · Cited by 42
Self-citationBen-Ami, R., & Kontoyiannis, D. P. (2012) · Virulence · doi:10.4161/viru.3.1.18886 · Cited by 39
Cited by
Resistance of Candida to azoles and echinocandins worldwide
Pristov, K. E., & Ghannoum, M. A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.028 · Cited by 706
“Echinocandins (lipopeptidic antifungals) interfere with glucan synthesis [1,14].”
BackgroundInfluentialCell wall glucans of fungi. A review
Ruiz-Herrera, J., & Ortiz-Castellanos, L. (2019) · The Cell Surface · doi:10.1016/j.tcsw.2019.100022 · Cited by 306
Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1
Hu, X., Yang, P., Chai, C., Liu, J., Sun, H., Wu, Y., Zhang, M., Zhang, M., Liu, X., & Yu, H. (2023) · Nature · doi:10.1038/s41586-023-05856-5 · Cited by 213
da Silva Dantas, A., Nogueira, F., Lee, K. K., Walker, L. A., Edmondson, M., Brand, A. C., Lenardon, M. D., & Gow, N. A. R. (2021) · Journal of Cell Science · doi:10.1242/jcs.258889 · Cited by 31
Self-citationβ-1,6-Glucan plays a central role in the structure and remodeling of the bilaminate fungal cell wall
Bekirian, C., Valsecchi, I., Bachellier-Bassi, S., Scandola, C., Guijarro, J. I., Chauvel, M., Mourer, T., Gow, N. A., Aimanianda, V. K., d'Enfert, C., et al. (2024) · eLife · doi:10.7554/elife.100569.3 · Cited by 28
Self-citation
Metadata
- Authors
- Lee, K. K., Kubo, K., Abdelaziz, J. A., Cunningham, I., de Silva Dantas, A., Chen, X., Okada, H., Ohya, Y., & Gow, N. A. R.
- Venue
- The Cell Surface
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 3
- Pages
- 12-25
- ISSN
- 2468-2330 (ISSN-L)
- OpenAlex
- W2893145193
- Cited by
- 52
- References
- 38
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.